全球人源化小鼠模型市場(2025-2029)
市場調查報告書
商品編碼
1748504

全球人源化小鼠模型市場(2025-2029)

Global Humanized Mouse Model Market 2025-2029

出版日期: | 出版商: TechNavio | 英文 214 Pages | 訂單完成後即時交付

價格

人源化小鼠模型市場預計將在 2024 年至 2029 年間達到 6,160 萬美元,預測期內的複合年成長率為 6.7%。

本報告對人源化小鼠模型市場進行了全面的分析,包括市場規模、預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

該報告提供了當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。市場受到個人化醫療日益普及、人性化小鼠模型的創新應用以及基因工程技術的進步的推動。

市場覆蓋
基準年 2025
年底 2029
預測期 2025-2029
成長動力 加速度
與前一年同期比較 6.5%
複合年成長率 6.7%
增量金額 6160萬美元

這項研究客觀地結合了一手和二手訊息,並參考了行業主要參與者的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告同時包含歷史數據和預測數據。

研究指出,企業之間的策略聯盟是推動未來幾年人源化小鼠模型市場成長的主要因素之一,而單株抗體產量的增加和整體動物影像的出現將帶來巨大的市場需求。

目錄

第1章執行摘要

  • 市場概覽

第2章 Technavio 分析

  • 價格、生命週期、顧客購買籃、採用率和購買標準的分析
  • 投入與差異化因素的重要性
  • 混亂的根源
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場區隔分析
  • 2024年市場規模
  • 2024-2029年市場展望

第5章 市場規模表現

  • 2019-2023年全球人源化小鼠模型市場
  • 2019-2023年產品類型細分分析
  • 2019-2023年最終用戶細分分析
  • 2019-2023年應用細分分析
  • 2019-2023年地理細分分析
  • 2019-2023年國家細分分析

第6章定性分析

  • 人工智慧的影響:人源化小鼠模型的全球市場

第7章五力分析

  • 五力模型摘要
  • 買家的議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

8.按產品類型細分市場

  • 市場區隔
  • 比較:依產品類型
  • GHMM:2024-2029 年市場規模及預測
  • 基於細胞的人源化小鼠模型:市場規模及預測(2024-2029)
  • 按產品類型分類的市場機會

第9章依最終用戶細分市場

  • 市場區隔
  • 比較:按最終用戶
  • 製藥和生物技術公司:2024-2029 年市場規模和預測
  • CRO:市場規模及預測(2024-2029)
  • 學術研究機構:市場規模及預測 2024-2029
  • 最終用戶的市場機會

第 10 章按應用分類的市場細分

  • 市場區隔
  • 比較:按應用
  • 腫瘤學:市場規模及預測(2024-2029)
  • 免疫學和感染疾病:市場規模和預測 2024-2029
  • 神經科學:市場規模及預測(2024-2029)
  • 毒理學和造血:2024 年至 2029 年市場規模和預測
  • 按應用分類的市場機會

第11章 客戶情況

  • 客戶概覽

第12章 地區情勢

  • 地理細分
  • 區域比較
  • 北美:2024-2029 年市場規模及預測
  • 歐洲:2024-2029 年市場規模及預測
  • 亞洲:2024-2029 年市場規模及預測
  • 世界其他地區:2024-2029 年市場規模及預測
  • 美國:市場規模及預測(2024-2029)
  • 中國:2024-2029年市場規模及預測
  • 德國:2024-2029年市場規模及預測
  • 法國:2024-2029年市場規模及預測
  • 加拿大:2024-2029 年市場規模及預測
  • 日本:2024-2029 年市場規模及預測
  • 巴西:2024-2029 年市場規模及預測
  • 英國:2024-2029 年市場規模及預測
  • 印度:2024-2029 年市場規模及預測
  • 韓國:2024-2029 年市場規模及預測
  • 按地區分類的市場機會

第13章 促進因素、挑戰、機會與限制因素

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機會與限制

第14章競爭格局

  • 概述
  • 競爭格局
  • 令人困惑的情況
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 企業排名指數
  • 公司市場定位
  • Altogen labs
  • Aragen Life Sciences Pvt. Ltd.
  • Biocytogen Pharmaceuticals Co. Ltd.
  • BioSafety Research Center Inc.
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • Creative Biolabs
  • Cyagen Biosciences
  • Gempharmatech Co. Ltd.
  • GenOway
  • HBM Holdings Ltd.
  • Hera Biolabs Inc.
  • ingenious targeting laboratory
  • JSR Corp.
  • Perkin Elmer Inc.

第16章 附錄

Product Code: IRTNTR43762

The humanized mouse model market is forecasted to grow by USD 61.6 mn during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.5%
CAGR6.7%
Incremental Value$61.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's humanized mouse model market is segmented as below:

By Product Type

    • GHMM
    • Cell-based humanized mouse model

By End-user

    • Pharmaceutical and biotechnology companies
    • CROs
    • Academic and research institutions

By Application

    • Oncology
    • Immunology and infectious diseases
    • Neuroscience
    • Toxicology and hematopoiesis

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the strategic alliances of companies as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of mabs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

    • Humanized Mouse Model Market sizing
    • Humanized Mouse Model Market forecast
    • Humanized Mouse Model Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen Pharmaceuticals Co. Ltd., BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., GenOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv Inc., JANVIER LABS, JSR Corp., Oncodesign Precision Medicine, Ozgene Pty Ltd., Perkin Elmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product Type
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Humanized Mouse Model Market 2019 - 2023
    • Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
  • 5.2 Product Type segment analysis 2019 - 2023
    • Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
  • 5.3 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.4 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Humanized Mouse Model Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product Type

  • 8.1 Market segments
    • Chart on Product Type - Market share 2024-2029 (%)
    • Data Table on Product Type - Market share 2024-2029 (%)
  • 8.2 Comparison by Product Type
    • Chart on Comparison by Product Type
    • Data Table on Comparison by Product Type
  • 8.3 GHMM - Market size and forecast 2024-2029
    • Chart on GHMM - Market size and forecast 2024-2029 ($ million)
    • Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
    • Chart on GHMM - Year-over-year growth 2024-2029 (%)
    • Data Table on GHMM - Year-over-year growth 2024-2029 (%)
  • 8.4 Cell-based humanized mouse model - Market size and forecast 2024-2029
    • Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
    • Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
    • Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Product Type
    • Market opportunity by Product Type ($ million)
    • Data Table on Market opportunity by Product Type ($ million)

9 Market Segmentation by End-user

  • 9.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 9.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
    • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
    • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
    • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
  • 9.4 CROs - Market size and forecast 2024-2029
    • Chart on CROs - Market size and forecast 2024-2029 ($ million)
    • Data Table on CROs - Market size and forecast 2024-2029 ($ million)
    • Chart on CROs - Year-over-year growth 2024-2029 (%)
    • Data Table on CROs - Year-over-year growth 2024-2029 (%)
  • 9.5 Academic and research institutions - Market size and forecast 2024-2029
    • Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
    • Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
    • Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
    • Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Application

  • 10.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 10.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 10.3 Oncology - Market size and forecast 2024-2029
    • Chart on Oncology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
    • Chart on Oncology - Year-over-year growth 2024-2029 (%)
    • Data Table on Oncology - Year-over-year growth 2024-2029 (%)
  • 10.4 Immunology and infectious diseases - Market size and forecast 2024-2029
    • Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
    • Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
    • Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
  • 10.5 Neuroscience - Market size and forecast 2024-2029
    • Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
    • Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
    • Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
    • Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
  • 10.6 Toxicology and hematopoiesis - Market size and forecast 2024-2029
    • Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
    • Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
    • Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
    • Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.11 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.12 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.13 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.14 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.15 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Altogen labs
    • Altogen labs - Overview
    • Altogen labs - Product / Service
    • Altogen labs - Key offerings
    • SWOT
  • 15.5 Aragen Life Sciences Pvt. Ltd.
    • Aragen Life Sciences Pvt. Ltd. - Overview
    • Aragen Life Sciences Pvt. Ltd. - Product / Service
    • Aragen Life Sciences Pvt. Ltd. - Key offerings
    • SWOT
  • 15.6 Biocytogen Pharmaceuticals Co. Ltd.
    • Biocytogen Pharmaceuticals Co. Ltd. - Overview
    • Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
    • Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
    • SWOT
  • 15.7 BioSafety Research Center Inc.
    • BioSafety Research Center Inc. - Overview
    • BioSafety Research Center Inc. - Product / Service
    • BioSafety Research Center Inc. - Key offerings
    • SWOT
  • 15.8 Champions Oncology Inc.
    • Champions Oncology Inc. - Overview
    • Champions Oncology Inc. - Product / Service
    • Champions Oncology Inc. - Key offerings
    • SWOT
  • 15.9 Charles River Laboratories International Inc.
    • Charles River Laboratories International Inc. - Overview
    • Charles River Laboratories International Inc. - Business segments
    • Charles River Laboratories International Inc. - Key offerings
    • Charles River Laboratories International Inc. - Segment focus
    • SWOT
  • 15.10 Creative Biolabs
    • Creative Biolabs - Overview
    • Creative Biolabs - Product / Service
    • Creative Biolabs - Key offerings
    • SWOT
  • 15.11 Cyagen Biosciences
    • Cyagen Biosciences - Overview
    • Cyagen Biosciences - Product / Service
    • Cyagen Biosciences - Key offerings
    • SWOT
  • 15.12 Gempharmatech Co. Ltd.
    • Gempharmatech Co. Ltd. - Overview
    • Gempharmatech Co. Ltd. - Product / Service
    • Gempharmatech Co. Ltd. - Key offerings
    • SWOT
  • 15.13 GenOway
    • GenOway - Overview
    • GenOway - Product / Service
    • GenOway - Key offerings
    • SWOT
  • 15.14 HBM Holdings Ltd.
    • HBM Holdings Ltd. - Overview
    • HBM Holdings Ltd. - Product / Service
    • HBM Holdings Ltd. - Key offerings
    • SWOT
  • 15.15 Hera Biolabs Inc.
    • Hera Biolabs Inc. - Overview
    • Hera Biolabs Inc. - Product / Service
    • Hera Biolabs Inc. - Key offerings
    • SWOT
  • 15.16 ingenious targeting laboratory
    • ingenious targeting laboratory - Overview
    • ingenious targeting laboratory - Product / Service
    • ingenious targeting laboratory - Key offerings
    • SWOT
  • 15.17 JSR Corp.
    • JSR Corp. - Overview
    • JSR Corp. - Business segments
    • JSR Corp. - Key offerings
    • JSR Corp. - Segment focus
    • SWOT
  • 15.18 Perkin Elmer Inc.
    • Perkin Elmer Inc. - Overview
    • Perkin Elmer Inc. - Business segments
    • Perkin Elmer Inc. - Key offerings
    • Perkin Elmer Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits8: Executive Summary - Chart on Incremental Growth
  • Exhibits9: Executive Summary - Data Table on Incremental Growth
  • Exhibits10: Executive Summary - Chart on Company Market Positioning
  • Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits12: Overview on criticality of inputs and factors of differentiation
  • Exhibits13: Overview on factors of disruption
  • Exhibits14: Impact of drivers and challenges in 2024 and 2029
  • Exhibits15: Parent Market
  • Exhibits16: Data Table on - Parent Market
  • Exhibits17: Market characteristics analysis
  • Exhibits18: Value chain analysis
  • Exhibits19: Offerings of companies included in the market definition
  • Exhibits20: Market segments
  • Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
  • Exhibits26: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits31: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits37: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits38: Chart on Product Type - Market share 2024-2029 (%)
  • Exhibits39: Data Table on Product Type - Market share 2024-2029 (%)
  • Exhibits40: Chart on Comparison by Product Type
  • Exhibits41: Data Table on Comparison by Product Type
  • Exhibits42: Chart on GHMM - Market size and forecast 2024-2029 ($ million)
  • Exhibits43: Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
  • Exhibits44: Chart on GHMM - Year-over-year growth 2024-2029 (%)
  • Exhibits45: Data Table on GHMM - Year-over-year growth 2024-2029 (%)
  • Exhibits46: Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
  • Exhibits47: Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
  • Exhibits48: Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
  • Exhibits49: Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
  • Exhibits50: Market opportunity by Product Type ($ million)
  • Exhibits51: Data Table on Market opportunity by Product Type ($ million)
  • Exhibits52: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits53: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits54: Chart on Comparison by End-user
  • Exhibits55: Data Table on Comparison by End-user
  • Exhibits56: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on CROs - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on CROs - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on CROs - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on CROs - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
  • Exhibits65: Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
  • Exhibits66: Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • Exhibits67: Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • Exhibits68: Market opportunity by End-user ($ million)
  • Exhibits69: Data Table on Market opportunity by End-user ($ million)
  • Exhibits70: Chart on Application - Market share 2024-2029 (%)
  • Exhibits71: Data Table on Application - Market share 2024-2029 (%)
  • Exhibits72: Chart on Comparison by Application
  • Exhibits73: Data Table on Comparison by Application
  • Exhibits74: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Oncology - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Market opportunity by Application ($ million)
  • Exhibits91: Data Table on Market opportunity by Application ($ million)
  • Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits95: Chart on Geographic comparison
  • Exhibits96: Data Table on Geographic comparison
  • Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits126: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits127: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits128: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Market opportunity By Geographical Landscape ($ million)
  • Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits155: Impact of drivers and challenges in 2024 and 2029
  • Exhibits156: Overview on criticality of inputs and factors of differentiation
  • Exhibits157: Overview on factors of disruption
  • Exhibits158: Impact of key risks on business
  • Exhibits159: Companies covered
  • Exhibits160: Company ranking index
  • Exhibits161: Matrix on companies position and classification
  • Exhibits162: Altogen labs - Overview
  • Exhibits163: Altogen labs - Product / Service
  • Exhibits164: Altogen labs - Key offerings
  • Exhibits165: SWOT
  • Exhibits166: Aragen Life Sciences Pvt. Ltd. - Overview
  • Exhibits167: Aragen Life Sciences Pvt. Ltd. - Product / Service
  • Exhibits168: Aragen Life Sciences Pvt. Ltd. - Key offerings
  • Exhibits169: SWOT
  • Exhibits170: Biocytogen Pharmaceuticals Co. Ltd. - Overview
  • Exhibits171: Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
  • Exhibits172: Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
  • Exhibits173: SWOT
  • Exhibits174: BioSafety Research Center Inc. - Overview
  • Exhibits175: BioSafety Research Center Inc. - Product / Service
  • Exhibits176: BioSafety Research Center Inc. - Key offerings
  • Exhibits177: SWOT
  • Exhibits178: Champions Oncology Inc. - Overview
  • Exhibits179: Champions Oncology Inc. - Product / Service
  • Exhibits180: Champions Oncology Inc. - Key offerings
  • Exhibits181: SWOT
  • Exhibits182: Charles River Laboratories International Inc. - Overview
  • Exhibits183: Charles River Laboratories International Inc. - Business segments
  • Exhibits184: Charles River Laboratories International Inc. - Key offerings
  • Exhibits185: Charles River Laboratories International Inc. - Segment focus
  • Exhibits186: SWOT
  • Exhibits187: Creative Biolabs - Overview
  • Exhibits188: Creative Biolabs - Product / Service
  • Exhibits189: Creative Biolabs - Key offerings
  • Exhibits190: SWOT
  • Exhibits191: Cyagen Biosciences - Overview
  • Exhibits192: Cyagen Biosciences - Product / Service
  • Exhibits193: Cyagen Biosciences - Key offerings
  • Exhibits194: SWOT
  • Exhibits195: Gempharmatech Co. Ltd. - Overview
  • Exhibits196: Gempharmatech Co. Ltd. - Product / Service
  • Exhibits197: Gempharmatech Co. Ltd. - Key offerings
  • Exhibits198: SWOT
  • Exhibits199: GenOway - Overview
  • Exhibits200: GenOway - Product / Service
  • Exhibits201: GenOway - Key offerings
  • Exhibits202: SWOT
  • Exhibits203: HBM Holdings Ltd. - Overview
  • Exhibits204: HBM Holdings Ltd. - Product / Service
  • Exhibits205: HBM Holdings Ltd. - Key offerings
  • Exhibits206: SWOT
  • Exhibits207: Hera Biolabs Inc. - Overview
  • Exhibits208: Hera Biolabs Inc. - Product / Service
  • Exhibits209: Hera Biolabs Inc. - Key offerings
  • Exhibits210: SWOT
  • Exhibits211: ingenious targeting laboratory - Overview
  • Exhibits212: ingenious targeting laboratory - Product / Service
  • Exhibits213: ingenious targeting laboratory - Key offerings
  • Exhibits214: SWOT
  • Exhibits215: JSR Corp. - Overview
  • Exhibits216: JSR Corp. - Business segments
  • Exhibits217: JSR Corp. - Key offerings
  • Exhibits218: JSR Corp. - Segment focus
  • Exhibits219: SWOT
  • Exhibits220: Perkin Elmer Inc. - Overview
  • Exhibits221: Perkin Elmer Inc. - Business segments
  • Exhibits222: Perkin Elmer Inc. - Key offerings
  • Exhibits223: Perkin Elmer Inc. - Segment focus
  • Exhibits224: SWOT
  • Exhibits225: Inclusions checklist
  • Exhibits226: Exclusions checklist
  • Exhibits227: Currency conversion rates for US$
  • Exhibits228: Research methodology
  • Exhibits229: Information sources
  • Exhibits230: Data validation
  • Exhibits231: Validation techniques employed for market sizing
  • Exhibits232: Data synthesis
  • Exhibits233: 360 degree market analysis
  • Exhibits234: List of abbreviations